See every side of every news story
Published loading...Updated

Rifaximin Lowers Hepatic Encephalopathy Risk in Cirrhosis

Summary by Medscape
Rifaximin was both effective and well-tolerated in reducing the risk for hepatic encephalopathy in patients with cirrhosis, according to a meta-analysis.

2 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Anti-Aging, Acupuncture and Health News broke the news in on Thursday, May 29, 2025.
Sources are mostly out of (0)